Sudarshan Pharma Industries Limited has scheduled a meeting of its Board of Directors for Wednesday, 12th August 2026. The primary purpose of this meeting is to consider and approve the Unaudited Standalone & Consolidated Financial Results of the Company for the quarter ended 30th June 2026 (Q1 FY27).
The disclosure is made pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Additionally, the company confirms that the Trading Window for dealing in the company's securities will remain closed until the expiry of 48 hours after the declaration of the financial results for the quarter ended 30th June 2026.